Comments on: “Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy”

Abstract

Get full access to this article

View all access options for this article.

References

Apolone

Montomoil

Manenti

, et al. Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy. Tumori. Epub ahead of print Nov 11, 2020. DOI: 10.1177/0300891620974755.

Hanson

Caliendo

Arias

, et al. Infectious Diseases Society of America guidelines on the diagnosis of coronavirus disease 2019. Clin Infect Dis. Epub ahead of print Jun 16, 2020. DOI: 10.1093/cid/ciaa760

Lisboa Bastos

Tavaziva

Abidi

, et al. Diagnostic accuracy of serological tests for COVID-19: systematic review and meta-analysis. BMJ. Epub ahead of print Jul 1, 2020. DOI: 10.1136/bmj.m2516

Lustig

Keler

Kolodny

, et al. Potential antigenic cross-reactivity between SARS-CoV-2 and Dengue viruses. Clin Infect Dis. Epub ahead of print Aug 14, 2020. DOI: 10.1093/cid/ciaa1207

Wang

Guo

, et al. A method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays. J Clin Microbiol 2020; 58: e00375–e00420.

Heliovaara

Aho

Aromaa

, et al. Smoking and risk of rheumatoid arthritis. J Rheumatol 1993; 20: 1830–1835.

Ingegnoli

Castelli

Gualtierotti

Rheumatoid factors: clinical applications. Dis Markers 2013; 35: 727–734.

Kharlamova

Dunn

Bedri

, et al. SARS-CoV-2 serological tests can generate false positive results for samples from patients with chronic inflammatory diseases. medRxiv (2020 Nov 13). DOI: https://doi.org/10.1101/2020.11.13.20231076